Literature DB >> 9223278

Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IkappaBalpha.

K Tashiro1, M P Pando, Y Kanegae, P M Wamsley, S Inoue, I M Verma.   

Abstract

The NF-kappaB/Rel proteins are sequestered in the cytoplasm in association with IkappaBalpha. In response to external signals, IkappaBalpha is phosphorylated, multi-ubiquitinated, and degraded by proteasomes, thereby releasing NF-kappaB/Rel proteins to migrate to the nucleus. We have cloned a mouse ubiquitin-conjugating enzyme (mE2), which associates with IkappaBalpha. mE2 is homologous to the yeast Ubc9/Hus5 ubiquitin-conjugating enzyme. A transdominant-negative mutant of mE2 had no effect on phosphorylation of IkappaBalpha, but delayed its degradation. Correspondingly, tumor necrosis factor-alpha-inducible NF-kappaB activity was diminished. We propose that mE2 is directly involved in the ubiquitin conjugation of IkappaBalpha, a pivotal step in its degradation pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223278      PMCID: PMC21520          DOI: 10.1073/pnas.94.15.7862

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Signal sequence trap. Expression cloning method for secreted proteins and type 1 membrane proteins.

Authors:  K Tashiro; T Nakano; T Honjo
Journal:  Methods Mol Biol       Date:  1997

2.  A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.

Authors:  J A Dyck; G G Maul; W H Miller; J D Chen; A Kakizuka; R M Evans
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

3.  The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.

Authors:  T Durfee; K Becherer; P L Chen; S H Yeh; Y Yang; A E Kilburn; W H Lee; S J Elledge
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

4.  Mammalian Ras interacts directly with the serine/threonine kinase Raf.

Authors:  A B Vojtek; S M Hollenberg; J A Cooper
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

Review 5.  The ubiquitin-proteasome proteolytic pathway.

Authors:  A Ciechanover
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

6.  The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

Authors:  V J Palombella; O J Rando; A L Goldberg; T Maniatis
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

7.  A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.

Authors:  V Chau; J W Tobias; A Bachmair; D Marriott; D J Ecker; D K Gonda; A Varshavsky
Journal:  Science       Date:  1989-03-24       Impact factor: 47.728

8.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

9.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.

Authors:  E B Traenckner; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  17 in total

1.  The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells.

Authors:  F Giorgino; O de Robertis; L Laviola; C Montrone; S Perrini; K C McCowen; R J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  cGMP-dependent protein kinase and the regulation of vascular smooth muscle cell gene expression: possible involvement of Elk-1 sumoylation.

Authors:  ChungSik Choi; Hassan Sellak; Felricia M Brown; Thomas M Lincoln
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-27       Impact factor: 4.733

3.  Conjugation of Smt3 to dorsal may potentiate the Drosophila immune response.

Authors:  Vinay Bhaskar; Matthew Smith; Albert J Courey
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions.

Authors:  Tareq Jaber; Christopher R Bohl; Gentry L Lewis; Charles Wood; John T West; Robert A Weldon
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

5.  Modulation of apoptosis and immune signaling pathways by the Hantaan virus nucleocapsid protein.

Authors:  Steven J Ontiveros; Qianjun Li; Colleen B Jonsson
Journal:  Virology       Date:  2010-03-12       Impact factor: 3.616

6.  The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme.

Authors:  S E Schwarz; K Matuschewski; D Liakopoulos; M Scheffner; S Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

7.  Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies.

Authors:  S R Chakrabarti; R Sood; S Nandi; G Nucifora
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

8.  Ubiquitin-Conjugating Enzyme 9 Phosphorylation as a Novel Mechanism for Potentiation of the Inflammatory Response.

Authors:  Maria Lauda Tomasi; Komal Ramani; Minjung Ryoo
Journal:  Am J Pathol       Date:  2016-09       Impact factor: 4.307

9.  MicroRNA-mediated regulation of Ubc9 expression in cancer cells.

Authors:  Fangting Wu; Shuomin Zhu; Yanna Ding; William T Beck; Yin-Yuan Mo
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

10.  SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.

Authors:  Sara Lovisa; Simona Citro; Maura Sonego; Alessandra Dall'Acqua; Valentina Ranzuglia; Stefania Berton; Alfonso Colombatti; Barbara Belletti; Susanna Chiocca; Monica Schiappacassi; Gustavo Baldassarre
Journal:  J Mol Cell Biol       Date:  2015-10-08       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.